Cipta Sarana Medika Tbk. vs Hatten Bali Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Hatten Bali Tbk. trades at Rp150 (market cap 401.08B, 2.45M 24h volume). The key difference: Hatten Bali Tbk. is far larger — about 2.5× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 2.45M). Which is the better fit depends on your goals.
| DKHH | WINE | |
|---|---|---|
Market Cap | 158.12B | 401.08B |
Volume | 8.21M | 2.45M |
Lot | 82.15K | 24.47K |
Turnover | 515.2M | 355.35M |
Average Price | 62.72 | 145.23 |
Value | 515.2M | 355.35M |
Indicative Equilibrium Price | 63 | 150 |
Indicative Equilibrium Volume | 1.33K | 37 |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Hatten bali, Tbk. (the Company) was established in Bali based on the Notarial Deed No. 90, dated April 15, 2000, drawn up before, I Putu Chandra, S.H Notary at Denpasar. The Company started its commercial operations in 2003.
Read more on WINE →